Provided by Tiger Trade Technology Pte. Ltd.

T. Rowe Price Health Care ETF

35.87
-0.0212-0.06%
Post-market: 35.85-0.0236-0.07%16:10 EDT
Volume:2K
Turnover:80.40K
Market Cap:31.39M
PE:- -
High:35.90
Open:35.74
Low:35.70
Close:35.89
52wk High:36.72
52wk Low:24.99
Shares:875.00K
Float Shares:875.00K
Volume Ratio:0.17
T/O Rate:0.26%
Dividend:0.16
Dividend Rate:0.45%
ROE:--
ROA:--
PB:--
PE(LYR):- -

Loading ...

Abbott VP, Controller John A. McCoy Jr Disposes of Common Shares Worth $8,685.45

Reuters
·
5 hours ago

Perrigo Co. PLC Stock Underperforms Thursday When Compared to Competitors

Dow Jones
·
6 hours ago

Steris PLC Stock Underperforms Thursday When Compared to Competitors

Dow Jones
·
6 hours ago

Edwards Lifesciences Corp. Stock Outperforms Competitors Despite Losses on the Day

Dow Jones
·
6 hours ago

Abbott Laboratories Stock Underperforms Thursday When Compared to Competitors

Dow Jones
·
6 hours ago

Gilead Sciences Inc. Stock Underperforms Thursday When Compared to Competitors Despite Daily Gains

Dow Jones
·
6 hours ago

Eli Lilly Stock (LLY) Gets a Bullish Note from JPMorgan Chase

TIPRANKS
·
8 hours ago

Healthcare Stocks Pick up Steam as Investors Play Offense and Defense

Dow Jones
·
9 hours ago

Gilead’s Arcus-Backed Cancer Trial Reaches Completion, Setting Up a Key Immuno-Oncology Catalyst

TIPRANKS
·
11 hours ago

Aspen Sees Mounjaro Africa Sales Above $124 Million in 2027

Reuters
·
Yesterday

Eikon Therapeutics Names Ching-Pin Chang as Chief Scientific Officer

Reuters
·
Yesterday

Superluminal Medicines: Financing Led by Bvf Partners; Alongside Existing Investors Nvidia, Eli Lilly & Co, Cooley, and Gaingels, Among Others

THOMSON REUTERS
·
Yesterday

Rothschild & Co Redburn Adjusts PT on Eli Lilly and Co. to $930 From $915, Keeps Neutral Rating

MT Newswires Live
·
Yesterday

Abbott Laboratories Stock Underperforms Wednesday When Compared to Competitors Despite Daily Gains

Dow Jones
·
Yesterday

Gilead CEO Daniel O'Day Disposes of USD 2.23 Million in Common Shares

Reuters
·
Yesterday

Option traders moderately bearish in Eli Lilly with shareslittle changed

TIPRANKS
·
Yesterday

Aspen Bets on Manufacturing Rebound, Obesity Drug Push for Growth

Reuters
·
Sep 02

Is Gilead Sciences (GILD) Fully Valued On Its New HIV And Cancer Drug Approvals?

Simply Wall St.
·
Sep 02

Steris PLC Stock Outperforms Competitors Despite Losses on the Day

Dow Jones
·
Sep 02

Gilead Sciences Inc. Stock Outperforms Competitors on Strong Trading Day

Dow Jones
·
Sep 02